PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
30606816,MTHFR C677T polymorphism increases MTX sensitivity via the inhibition of S-adenosylmethionine and de novo purine synthesis,"Wang YC, Wu MT, Tang FY, Chen DY, Ko HA, Shane B, Huang WN, Chiang EP.",Clin Sci (Lond). 2019 Jan 25;133(2):253-267. doi: 10.1042/CS20180932. Print 2019 Jan 31.,Wang YC,Clin Sci (Lond),2019,2019/01/05,,,10.1042/CS20180932
32318793,Combined effect of polymorphisms of MTHFR and MTR and arsenic methylation capacity on developmental delay in preschool children in Taiwan,"Hsueh YM, Lin YC, Chung CJ, Huang YL, Hsieh RL, Huang PT, Wu MY, Shiue HS, Chien SN, Lee CY, Lin MI, Mu SC, Su CT.",Arch Toxicol. 2020 Jun;94(6):2027-2038. doi: 10.1007/s00204-020-02745-y. Epub 2020 Apr 21.,Hsueh YM,Arch Toxicol,2020,2020/04/23,,,10.1007/s00204-020-02745-y
32330571,Impact of the MTHFR C677T polymorphism on one-carbon metabolites: Evidence from a randomised trial of riboflavin supplementation,"Rooney M, Bottiglieri T, Wasek-Patterson B, McMahon A, Hughes CF, McCann A, Horigan G, Strain JJ, McNulty H, Ward M.",Biochimie. 2020 Jun;173:91-99. doi: 10.1016/j.biochi.2020.04.004. Epub 2020 Apr 21.,Rooney M,Biochimie,2020,2020/04/25,,,10.1016/j.biochi.2020.04.004
20220206,Choline intake exceeding current dietary recommendations preserves markers of cellular methylation in a genetic subgroup of folate-compromised men,"Shin W, Yan J, Abratte CM, Vermeylen F, Caudill MA.",J Nutr. 2010 May;140(5):975-80. doi: 10.3945/jn.110.121186. Epub 2010 Mar 10.,Shin W,J Nutr,2010,2010/03/12,PMC2855263,,10.3945/jn.110.121186
17967524,Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer,"Marchal C, Redondo M, Reyes-Engel A, Perea-Milla E, Gaitan MJ, Machuca J, Diaz F, Caballero J, Carnero J.",Eur J Surg Oncol. 2008 Jul;34(7):805-10. doi: 10.1016/j.ejso.2007.09.008. Epub 2007 Oct 29.,Marchal C,Eur J Surg Oncol,2008,2007/10/31,,,10.1016/j.ejso.2007.09.008
15217535,Effect of the methylenetetrahydrofolate reductase C677T polymorphism on patients with cisplatin/gemcitabine-treated stage IV non-small-cell lung cancer,"Alberola V, Sarries C, Rosell R, Taron M, de las Peñas R, Camps C, Massuti B, Insa A, Garcia-Gomez R, Isla D, Artal A, Muñoz MA, Cobo M, Bover I, Gonzalez-Larria JL, Terrasa J, Almenar D, Barcelo R, Diz P, Sanchez-Ronco M, Sanchez JJ.",Clin Lung Cancer. 2004 May;5(6):360-5. doi: 10.3816/clc.2004.n.014.,Alberola V,Clin Lung Cancer,2004,2004/06/26,,,10.3816/clc.2004.n.014